These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 7509074
21. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, Smith AE, Welsh MJ. Science; 1991 Jul 12; 253(5016):202-5. PubMed ID: 1712984 [Abstract] [Full Text] [Related]
22. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Li C, Ramjeesingh M, Reyes E, Jensen T, Chang X, Rommens JM, Bear CE. Nat Genet; 1993 Apr 12; 3(4):311-6. PubMed ID: 7526932 [Abstract] [Full Text] [Related]
23. Channel protein engineering: synthetic 22-mer peptide from the primary structure of the voltage-sensitive sodium channel forms ionic channels in lipid bilayers. Oiki S, Danho W, Montal M. Proc Natl Acad Sci U S A; 1988 Apr 12; 85(7):2393-7. PubMed ID: 2451248 [Abstract] [Full Text] [Related]
25. Architecture and functional properties of the CFTR channel pore. Linsdell P. Cell Mol Life Sci; 2017 Jan 12; 74(1):67-83. PubMed ID: 27699452 [Abstract] [Full Text] [Related]
26. A change in gating mode leading to increased intrinsic Cl- channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease. Champigny G, Imler JL, Puchelle E, Dalemans W, Gribkoff V, Hinnrasky J, Dott K, Barbry P, Pavirani A, Lazdunski M. EMBO J; 1995 Jun 01; 14(11):2417-23. PubMed ID: 7540133 [Abstract] [Full Text] [Related]
27. Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents. Cai Z, Lansdell KA, Sheppard DN. Br J Pharmacol; 1999 Sep 01; 128(1):108-18. PubMed ID: 10498841 [Abstract] [Full Text] [Related]
28. Transmembrane domain of cystic fibrosis transmembrane conductance regulator: design, characterization, and secondary structure of synthetic peptides m1-m6. Wigley WC, Vijayakumar S, Jones JD, Slaughter C, Thomas PJ. Biochemistry; 1998 Jan 20; 37(3):844-53. PubMed ID: 9454574 [Abstract] [Full Text] [Related]
29. Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells. O'Riordan CR, Erickson A, Bear C, Li C, Manavalan P, Wang KX, Marshall J, Scheule RK, McPherson JM, Cheng SH. J Biol Chem; 1995 Jul 14; 270(28):17033-43. PubMed ID: 7542655 [Abstract] [Full Text] [Related]
30. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. Denning GM, Ostedgaard LS, Cheng SH, Smith AE, Welsh MJ. J Clin Invest; 1992 Jan 14; 89(1):339-49. PubMed ID: 1370301 [Abstract] [Full Text] [Related]
34. Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator. Cotten JF, Ostedgaard LS, Carson MR, Welsh MJ. J Biol Chem; 1996 Aug 30; 271(35):21279-84. PubMed ID: 8702904 [Abstract] [Full Text] [Related]
35. Stable dimeric assembly of the second membrane-spanning domain of CFTR (cystic fibrosis transmembrane conductance regulator) reconstitutes a chloride-selective pore. Ramjeesingh M, Ugwu F, Li C, Dhani S, Huan LJ, Wang Y, Bear CE. Biochem J; 2003 Nov 01; 375(Pt 3):633-41. PubMed ID: 12892562 [Abstract] [Full Text] [Related]